መነሻ › አልዛይመር በሽታ › አሪዞና
በአሪዞና ለአልዛይመር በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአልዛይመር በሽታ የሚደረጉ 23 ጥናቶች በአሪዞና ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአሪዞና ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Phoenix
- Clinical Site, Scottsdale
- Clinical Site, Tucson
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2609, Chandler
- Imaging Endpoints, Scottsdale
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Gilbert Neurology Partners - PLLC - Avacare, Gilbert
- Banner Alzheimer's Institute, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06585787A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- TrialSphere Corp, Chandler
- HonorHealth Research Institute, Scottsdale
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Banner Alzheimer's Institute, Phoenix
- Barrow Neurological Institute, Phoenix
- Clinical Endpoints, Scottsdale
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Banner Alzheimer?s Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Imaging Endpoints, Scottsdale
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Chandler Clinical Trials, LLC, Chandler
- Local Institution - 2631, Chandler
- TrialSphere Corp, Chandler
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0040, Scottsdale
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06808984A Study of AMDX-2011P in Participants With Alzheimer's Disease
- Associated Retina Consultants, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT06514001The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- University of Arizona, Tucson
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05988385Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Arizona State University, Phoenix
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ45 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁላይ 2026 · NCT05980052A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Banner Alzheimer's Institute, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Gilbert Neurology Partners/CCT Research, Gilbert
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Banner Alzheimers Institute, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Barrow Neurological Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Barrow Neurological Institute, Phoenix
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ25 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT04165109A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- Arizona State University, Phoenix
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT05877196Early-Stage Partner in Care Living Alone Plus
- Arizona State University, Phoenix
ተሳታዮችን በመፈለግ ላይ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06962111Repurposing Siponimod for Alzheimer's Disease
- St. Joseph's Hospital and Medical Center, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ4 ማርች 2026 · NCT06639282A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- Mayo Clinic Arizona, Scottsdale
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ50 እስከ 95 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT06057909Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Banner Alzheimer's Institute, Phoenix
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 110 · ሁሉም ጾታዎች · የተሻሻለው በ16 ዲሴም 2025 · NCT02022943PROMIS and Mobility Evaluation in Sarcoma Patients
- Mayo Clinic, Phoenix
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኖቬም 2025 · NCT07227961ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።